Weight-based dosing vs fixed dosing of pembrolizumab: an economic analysis.

Weight-based dosing vs fixed dosing of pembrolizumab: an economic analysis.
Clin Adv Hematol Oncol. 2018 Aug;16(8):549-551
Authors: Goldstein D
PMID: 30148826 [PubMed - in process]

Source: Clinical Advances in Hematology and Oncology - August 29, 2018 Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research